📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The discovery of novel 10,11-dihydro-5H-dibenz[b,f]azepine SIRT2 inhibitors (2012)

First Author: Di Fruscia P

Attributed to: Validation of the Commercial Potential of a Novel in silico Approach for Drug Discovery and Development funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c2md00290f

PubMed Identifier: 24340169

Publication URI: http://europepmc.org/abstract/MED/24340169

Type: Journal Article/Review

Parent Publication: MedChemComm

Issue: 3

ISSN: 2040-2503